Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$637
-$84 QoQ
Shares Held
90
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#153
of 164 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $25,620,221 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,837 | $5,545,942 | |
| 2 | ABBV |
AbbVie Inc.
|
19,010 | $4,783,676 | |
| 3 | LLY |
ELI LILLY & Co
|
3,909 | $4,688,572 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,199 | $4,651,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,282 | $1,678,047 | |
| 6 | AMGN |
Amgen Inc
|
4,076 | $1,476,001 | |
| 7 | PFE |
Pfizer Inc
|
33,216 | $799,841 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,165 | $758,567 |
All Filings in GRFS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $637 | 90 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $721 | 90 | Shares | Sole | 2026-05-11 | |
| 2021-06-30 | $832 | 48 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||